Skip to Accessibility Tools Skip to Content Skip to Footer

What Causes Asthma?

It is helpful to know how the lungs work normally in order to understand how the airways become blocked (obstructed) when you have asthma.

In normal breathing, your diaphragm, which is a large muscle at the bottom of your chest cavity, tightens up (contracts).1 This action makes more space in your chest. Your lungs expand to fill the space, which draws air in through your mouth and nose. To breathe out, your diaphragm relaxes, making the space in your chest smaller. This action forces air out of your lungs. In a person with healthy lungs, the muscles around the airways are relaxed, and air can flow in and out easily.

What is an obstructive lung disease?

Asthma is an obstructive lung disease. An obstructive lung disease is one in which airflow in the smaller airways is impeded or “obstructed,” making it difficult for you to exhale. Basically, it is hard for the air to get out of your lungs.

In a person with obstructive lung disease, the lungs expand normally and the air usually has no problem traveling into the lungs. The problem starts because the air cannot get out through narrowed airways. It takes longer to breathe out than in.2 Before you have finished exhaling, you feel the need to inhale. When this happens – usually during asthma attacks in people with severe asthma – some air gets stuck in your lungs at the end of the breath. This is called “air trapping.”2 Air trapping makes it hard for the next breath to get in. Once this cycle starts, it becomes harder and harder to breathe.

What makes it hard for air to get out of my lungs?

Airway narrowing

During an asthma attack, it is hard for air to get out of your lungs because your airways get smaller.3 Your airways are tubes surrounded by muscle. Those muscles contract during an attack, and your airways become smaller (Figure 1).4 Less air is able to travel through the tubes, so air starts to build up in the lungs. As a result, you may wheeze, cough, feel short of breath, or feel chest tightness. Some asthma medications help the muscles to relax, and so the airways open up and air can travel out again.4

Figure 1. Normal Airways and Airway During Asthma Symptoms

Normal airways next to airways affected by asthma

From: National Heart, Lung, and Blood Institute. What is asthma? Accessed 12/8/14 at
National Heart, Lung, and Blood Institute

Swelling and mucus

It is possible to feel short of breath even when you are not having an asthma attack. Because of inflammation in your airways, the airways swell and fill with mucus (Figure 1).3,4 The narrowing and blockage of the airways can make it harder for air to get in and out of the lungs. Medications that reduce inflammation also reduce airway swelling.4

Muscle and cell overgrowth

In some people with asthma, the muscles around the airways become thicker.3 The layers of cells that line the airway become overgrown. It is not known yet whether these changes are permanent. Currently, there are no medications that can fully reverse this process.

What does reversibility mean?

Reversibility means that lung function improves after taking a medication that opens the airways.5 Reversibility is a sign of asthma. (If the obstruction is not reversible, it is a sign of COPD or chronic obstructive pulmonary disease.)

To test whether the airway obstruction is reversible, spirometry is done before and after taking albuterol.5 If your FEV1 increases by 12% or 200 mL after taking albuterol, it means that the airway blockage is reversible.1 FEV1 is the amount of air you can forcefully exhale in one second.

What is airway inflammation?

Inflammation is the root of the problem in asthma.3 Even when you are not experiencing asthma symptoms, your airways can still be inflamed.6 Inflammation leads to:3

  • Airway sensitivity (also called “hyperresponsiveness” or “irritability”)
  • Limited airflow (also called “airway obstruction”)

Inflammation makes the airways very sensitive to allergens, mold, chemicals, cold air, and viruses.4 The airways react to these triggers by becoming narrow, which makes it difficult for you to breathe out (Figure 2).3

Figure 2. How Inflammation Leads to Asthma Symptoms

Adapted from: National Heart, Lung, and Blood Institute. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma – Full Report 2007. Accessed 11/12/14 at:; Figure 2–1, pg 13.

Inflammation, sensitivity, and obstruction can interact in different ways, meaning that everyone’s asthma is a little different.3 A person with asthma can have some or all of the typical symptoms. Asthma can be mild, moderate, or severe. Certain medications work better for some people than others.

How does inflammation cause airway sensitivity and obstruction?

Many different types of inflammatory cells and signaling chemicals play a role in asthma. Allergens turns on ‘mast cells’ and ‘dendritic cells’.7 These cells tell ‘Th2 cells’ to send out signaling chemicals called ‘interleukins.’ Interleukins turn on other signals that are responsible for some allergy symptoms, mucus production, airway narrowing, and increasing the number of eosinophils. About half the people with severe asthma have high eosinophils, which are a type of white blood cell.8 Signals from other cells increase the inflammation, making the airways more sensitive. The most important cell types are described in the Table.3,7,9

Table. Inflammatory Cells Involved in Asthma

Cell Type
What the cell does
Mast cells
Allergens turn on mast cells. Mast cells release histamine, which causes allergy symptoms. They also produce chemicals called leukotrienes that cause airway narrowing and sensitivity. Mast cells have a role in turning on Th2 cells.
Dendritic cells
Allergens turn on dendritic cells, which turn on Th2 cells.
Th2 cells (“Type 2 helper cells”)
Th2 cells produce signaling chemicals called interleukins, which start the signaling chain that causes allergy symptoms, airway narrowing, and high levels of eosinophils.
Eosinophils produce leukotrienes, which cause airway narrowing. They produce other signals that increase inflammation.

National Heart, Lung, and Blood Institute. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma – Full Report 2007; pg 16-18; Kraft M. N Engl J Med. 2011;365:1141-1144; Berger A. BMJ. 1999;319:90.

Medications that block interleukins are under investigation right now.10,11 These medications may be helpful for people with moderate to severe asthma and high eosinophil levels.

How is airway inflammation measured?

Two tests measure airway inflammation: exhaled nitric oxide and mucus (sputum) eosinophils.3 The level of eosinophils in the blood may also be used, because it is easier to measure and it indicates the level of eosinophils in the lung.12 These tests are not used as often as measures of lung function, such as spirometry.

How is airway sensitivity measured?

It is possible to measure how sensitive your airways with a methacholine challenge.3 This test rules out conditions that mimic asthma, such as vocal cord dysfunction and other obstructive lung diseases, such as chronic bronchitis and emphysema. Finding out that you have sensitive airways helps to confirm the diagnosis of asthma.

Written by: Sarah O'Brien | Last Reviewed: May 2016.
  1. National Heart, Lung, and Blood Institute. What happens when you breath? Accessed 1/18/15 at:
  2. University of Virgina School of Medicine. Asthma attacks. Accessed 1/18/15 at:
  3. National Heart, Lung, and Blood Institute. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma - Full Report 2007. Accessed 11/12/14 at:
  4. National Heart, Lung, and Blood Institute. What Is Asthma? Accessed 12/8/14 at
  5. Petty TL, Enright PL. Simple office spirometry for primary care practitioners. November 2003. Accessed 1/25/15 at:
  6. Locksley RM. Asthma and allergic inflammation. Cell. 2010;140:777-783.
  7. Kraft M. Asthma phenotypes and interleukin-13--moving closer to personalized medicine. N Engl J Med. 2011;365:1141-1144.
  8. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716-725.
  9. Berger A. What are leukotrienes and how do they work in asthma? BMJ. 1999;319:90.
  10. Ortega HG, Liu MC, Pavord ID, et al; MENSA Investigators. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371:1198-1207.
  11. Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368:2455-2466.
  12. Schleich FN, Manise M, Sele J, et al. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med. 2013;13:11.